162 related articles for article (PubMed ID: 31737687)
1. Immunoregulatory Effects of Subcutaneous Immunotherapy on Lymphocyte Subgroups and Cytokines in Children with Asthma.
He YT; Zhou Y; Shao Q; Gan C; Chen M; Bao YL; Gu HY; Zhang SL; Cui Y; Tian M
J Immunol Res; 2019; 2019():7024905. PubMed ID: 31737687
[TBL] [Abstract][Full Text] [Related]
2. Specific immunoglobulin G4 correlates with Th2 cytokine reduction in patients with allergic asthma treated by Dermatophagoides pteronyssinus subcutaneous immunotherapy.
Su Q; Ren N; Feng M; Zeng X; Dong Y; Xian M; Shi X; Luo T; Liu G; Li J
World Allergy Organ J; 2023 Jan; 16(1):100715. PubMed ID: 36820309
[TBL] [Abstract][Full Text] [Related]
3. Phenotype analyses of IL-10-producing Foxp3
Matsuda M; Morie Y; Oze H; Doi K; Tsutsumi T; Hamaguchi J; Inaba M; Nabe T
Int Immunopharmacol; 2018 Aug; 61():297-305. PubMed ID: 29909233
[TBL] [Abstract][Full Text] [Related]
4. A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes.
Keles S; Karakoc-Aydiner E; Ozen A; Izgi AG; Tevetoglu A; Akkoc T; Bahceciler NN; Barlan I
J Allergy Clin Immunol; 2011 Oct; 128(4):808-815.e7. PubMed ID: 21641635
[TBL] [Abstract][Full Text] [Related]
5. ICS/LABA Combined With Subcutaneous Immunotherapy Modulates the Th17/Treg Imbalance in Asthmatic Children.
Dai H; Zheng R; Wang L; Wan J; Tong Y; Zhao W; Zhang W
Front Immunol; 2022; 13():779072. PubMed ID: 35355985
[TBL] [Abstract][Full Text] [Related]
6. Regulatory T cells and type 2 innate lymphoid cell-dependent asthma.
Aron JL; Akbari O
Allergy; 2017 Aug; 72(8):1148-1155. PubMed ID: 28160290
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D as an adjunct to subcutaneous allergen immunotherapy in asthmatic children sensitized to house dust mite.
Baris S; Kiykim A; Ozen A; Tulunay A; Karakoc-Aydiner E; Barlan IB
Allergy; 2014 Feb; 69(2):246-53. PubMed ID: 24180595
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous immunotherapy suppresses Th2 inflammation and induces neutralizing antibodies, but sublingual immunotherapy suppresses airway hyperresponsiveness in grass pollen mouse models for allergic asthma.
Hesse L; Brouwer U; Petersen AH; Gras R; Bosman L; Brimnes J; Oude Elberink JNG; van Oosterhout AJM; Nawijn MC
Clin Exp Allergy; 2018 Aug; 48(8):1035-1049. PubMed ID: 29752757
[TBL] [Abstract][Full Text] [Related]
9. Dental follicle mesenchymal stem cells down-regulate Th2-mediated immune response in asthmatic patients mononuclear cells.
Genç D; Zibandeh N; Nain E; Gökalp M; Özen AO; Göker MK; Akkoç T
Clin Exp Allergy; 2018 Jun; 48(6):663-678. PubMed ID: 29498435
[TBL] [Abstract][Full Text] [Related]
10. Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration.
Antúnez C; Mayorga C; Corzo JL; Jurado A; Torres MJ
Pediatr Allergy Immunol; 2008 May; 19(3):210-8. PubMed ID: 18399897
[TBL] [Abstract][Full Text] [Related]
11. Identification of Robust Biomarkers for Early Predicting Efficacy of Subcutaneous Immunotherapy in Children With House Dust Mite-Induced Allergic Rhinitis by Multiple Cytokine Profiling.
Xie S; Fan R; Tang Q; Cai X; Zhang H; Wang F; Xie S; Gao K; Zhang J; Xie Z; Jiang W
Front Immunol; 2021; 12():805404. PubMed ID: 35095890
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and safety of dust mite subcutaneous immunotherapy in children with allergic asthma： a prospective randomized controlled study].
Wang YN; Lu SQ; Chen H; Li YQ; Lu HY; Zhu H; Chang M
Zhongguo Dang Dai Er Ke Za Zhi; 2024 Jun; 26(6):559-566. PubMed ID: 38926371
[TBL] [Abstract][Full Text] [Related]
13. Suppression of Immunotherapy on Group 2 Innate Lymphoid Cells in Allergic Rhinitis.
Fan DC; Wang XD; Wang CS; Wang Y; Cao FF; Zhang L
Chin Med J (Engl); 2016 Dec; 129(23):2824-2828. PubMed ID: 27900996
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of transdermal immunotherapy with biodegradable microneedle patches in a murine asthma model.
Park KH; Oh EY; Han H; Kim JD; Kim SJ; Jeong KY; Kim JH; Park CO; Kim SR; Lee JH; Jeong DH; Yong TS; Lee KH; Park JW
Clin Exp Allergy; 2020 Sep; 50(9):1084-1092. PubMed ID: 32557846
[TBL] [Abstract][Full Text] [Related]
15. [A comparision of the effects of subcutaneous and sublingual immunotherapy on immunological responses in children with asthma].
Miao Q; Wang J; Xu W; Guan H; Wang Q; Liu XY; Huang HJ; Ren YX; Wang Y; Liu YG; Li Z; Xiang L
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Nov; 17(11):1210-6. PubMed ID: 26575880
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial.
Eifan AO; Akkoc T; Yildiz A; Keles S; Ozdemir C; Bahceciler NN; Barlan IB
Clin Exp Allergy; 2010 Jun; 40(6):922-32. PubMed ID: 20100188
[TBL] [Abstract][Full Text] [Related]
17. Changes in CD4+CD25+FoxP3+ Regulatory T Cells and Serum Cytokines in Sublingual and Subcutaneous Immunotherapy in Allergic Rhinitis with or without Asthma.
Xian M; Feng M; Dong Y; Wei N; Su Q; Li J
Int Arch Allergy Immunol; 2020; 181(1):71-80. PubMed ID: 31722337
[TBL] [Abstract][Full Text] [Related]
18. [Retrospective Study of Mite-Specific Subcutaneous Immunotherapy in Children].
Duan QN; Yan M; Liu F; Chen MX; Yang LH; Zhao DY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Sep; 52(5):849-854. PubMed ID: 34622604
[TBL] [Abstract][Full Text] [Related]
19. Initial immunological changes as predictors for house dust mite immunotherapy response.
Gómez E; Fernández TD; Doña I; Rondon C; Campo P; Gomez F; Salas M; Gonzalez M; Perkins JR; Palomares F; Blanca M; Torres MJ; Mayorga C
Clin Exp Allergy; 2015 Oct; 45(10):1542-53. PubMed ID: 26032922
[TBL] [Abstract][Full Text] [Related]
20. T cells are necessary for ILC2 activation in house dust mite-induced allergic airway inflammation in mice.
Li BW; de Bruijn MJ; Tindemans I; Lukkes M; KleinJan A; Hoogsteden HC; Hendriks RW
Eur J Immunol; 2016 Jun; 46(6):1392-403. PubMed ID: 27062360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
